As a privately-owned, biopharma company, Ferring focuses on developing life-changing innovations that help people live better lives. Grounded in a 70-year commitment to science and research, we are relentless in our pursuit of therapies that help people build families, stay healthy, and fight disease.
We’re committed to being the world-leading, most trusted healthcare company in reproductive medicine and maternal health, and a leader in specialty areas within gastroenterology and orthopaedics. With that ambition in mind, we’re dedicated to following the science, conducting exhaustive research, and going where others may not—which means that people will always come first.
Since launching our U.S. operations in 1980, Ferring continues to sustain record growth, introduce new products, and expand our operations. Today, through our own research and strategic acquisitions, we’re working to achieve today’s ‘firsts:’ unlocking the power of the human microbiome, discovering new, more accessible ways for people to start and build families, and tackling some of the most debilitating diseases and conditions of our time.
Ferring By the Numbers
We know that people must always come first
- Globally, we reach millions of patients across 110 countries.
- We are 6,000+ strong across the globe, including 700+ employees and 150 researchers right here in the U.S.
- Globally, we bring 70 years of experience developing innovative therapies across multiple conditions. We offer the most complete reproductive medicine portfolio in the U.S.
- We invest 17% of our global revenue in research and development. In the U.S., we aim to consistently grow revenue at a double-digit rate each year.